ICU drug showdown: can new combo calm racing hearts and save lives?
NCT ID NCT02118467
Summary
This study aims to find out if using the blood pressure drugs phenylephrine and vasopressin is better than the standard drugs norepinephrine and epinephrine for adults in the ICU with shock. The main goal is to see if the new drug combination causes fewer dangerous fast heart rhythms and leads to more people surviving their hospital stay. About 836 patients whose low blood pressure doesn't improve with IV fluids will be randomly assigned to receive one of the two drug combinations without their doctors knowing which one.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.